- 2023 Multidisciplinary Oncology Review
- 2022
- Videos
- 2021
- 2020
- 2019
- Hematology & Medical Oncology Review 2019
- 2018
- Events
Playback speed
10 seconds
ASH Update on Myelofibrosis: What Are the Outcomes After Ruxolitinib Discontinuation? What Is the Additional Benefit of Parsaclisib & Ruxolitinib? Does LSD1 Improve Symptoms and OS?
125 views
March 8, 2021
Comments 0
Login to view comments.
Click here to Login
ASH Review VIRTUAL 2020: Current Updates in Hematologic Diseases